Moderna's shares soared during the Covid vaccine boom before crashing as demand faded. A cancer breakthrough has now ...

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the ...

Since 1965, messenger RNA (mRNA) vaccines have been studied for cancer treatment, but it was the technological advances in vaccines during the COVID pandemic that helped accelerate research. Currently ...

When there’s a breakthrough in mRNA-based medicines, molecular biologist and geneticist Seth Cheetham is often caught up in the media whirlwind. From his beginnings in basic research studying how RNA ...

Licensure was supported by phase 3 efficacy in adults 50–64 years and positioned as a platform advance for older populations at higher influenza complication risk. Trial outcomes showed 26.6% relative ...